Universal flu vaccine takes first step in human trials
NCT ID NCT06460064
First seen Apr 23, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This early-phase study tested a new universal influenza vaccine in 144 healthy adults aged 18 to 40. The goal was to check the vaccine's safety and how well it triggers an immune response. Participants received either the vaccine or a placebo, and researchers monitored for side effects and immune markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Vaccinology
Ghent, Corneel Heymanslaan 10, 9000, Belgium
Conditions
Explore the condition pages connected to this study.